|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2010-3-31
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Single-agent gemcitabine became standard first-line treatment for advanced pancreatic cancer after demonstration of superiority compared with fluorouracil. The Gruppo Italiano Pancreas 1 randomized phase III trial aimed to compare gemcitabine plus cisplatin versus gemcitabine alone (ClinicalTrials.gov ID NCT00813696).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
pubmed-author:CartenìGiacomoG,
pubmed-author:CavannaLuigiL,
pubmed-author:CiaparroneMarcoM,
pubmed-author:ColucciGiuseppeG,
pubmed-author:DaprettoElisaE,
pubmed-author:Di CostanzoFrancescoF,
pubmed-author:Di MaioMassimoM,
pubmed-author:FalconiMassimoM,
pubmed-author:GalloCiroC,
pubmed-author:GebbiaVittorioV,
pubmed-author:GiulianiFrancescoF,
pubmed-author:Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente...,
pubmed-author:Gruppo Oncologico Italia Meridionale (GOIM),
pubmed-author:Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC),
pubmed-author:LabiancaRobertoR,
pubmed-author:MaielloEvaristoE,
pubmed-author:ManzioneLuigiL,
pubmed-author:MassiddaBrunoB,
pubmed-author:PederzoliPaoloP,
pubmed-author:PerroneFrancescoF,
pubmed-author:PiazzaElenaE,
pubmed-author:SannicolòMirellaM,
pubmed-author:TestaAntonioA
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1645-51
|
|
pubmed:meshHeading |
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 study.
|
|
pubmed:affiliation |
Medical and Experimental Oncology Unit, Oncology Institute Giovanni Paolo II, Bari, Italy.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase III
|
